This e-Learning programme is endorsed by the
European Society for Blood and Marrow Transplantation (EBMT).
Upon completion, you will receive a certificate and can self-report
the course to earn continuing professional development (CPD) points.
This site has been created for United Kingdom (UK) and Ireland (IE) healthcare professionals only.
By entering this site, you are confirming that you are a UK/IE healthcare professional.
This is a Jazz Pharmaceutical's website and contains promotional information.
Please choose what best describes you...
You are leaving this website and being redirected. The links below are neither owned nor controlled by Jazz. Jazz is not responsible for the content of any third-party sites.
For information for those in the UK click here to view the Defitelio▼(defibrotide) Patient Information Leaflet on the EMC (electronic medicines compendium) website.
For information for those in Northern Ireland click here to view the Defitelio▼(defibrotide) Patient Information Leaflet on the EMC (electronic medicines compendium) website.
For information for those in the Republic of Ireland click here to view the Defitelio▼(defibrotide) Patient Information Leaflet on the EMA (European Medicines Agency) website.
Reporting of side effects
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.
UK-DEF-2300068 I January 2024